Literature DB >> 14593698

The cell cycle and human neurodegenerative disease.

Inez Vincent1, Chong In Pae, Janice L Hallows.   

Abstract

The mechanism by which neurons die in human neurodegenerative diseases remains an enigma till today. Terminally differentiated neurons of normal brain are incapable of cell division. However, accumulating evidence has suggested that aberrant activation of the cell cycle in certain degenerative diseases leads to their demise. In Alzheimer's disease, regulators spanning every phase of the cell cycle are upregulated in affected neurons, leading to successful DNA replication, but unsuccessful mitosis. The end point of this nonproductive cycle of division is death. Elucidating the details of this cell cycle-mediated degenerative cascade may lead to novel strategies for curbing the onset and progression of degenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593698

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  15 in total

1.  Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.

Authors:  Cathy Andorfer; Christopher M Acker; Yvonne Kress; Patrick R Hof; Karen Duff; Peter Davies
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

Review 2.  Cell cycle molecules define a pathway required for neuron death in development and disease.

Authors:  Lloyd A Greene; David X Liu; Carol M Troy; Subhas C Biswas
Journal:  Biochim Biophys Acta       Date:  2006-12-13

3.  A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.

Authors:  Ya-Li Zheng; Sashi Kesavapany; Maneth Gravell; Rebecca S Hamilton; Manfred Schubert; Niranjana Amin; Wayne Albers; Philip Grant; Harish C Pant
Journal:  EMBO J       Date:  2004-12-09       Impact factor: 11.598

4.  Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.

Authors:  Min Zhang; Jin Li; Paramita Chakrabarty; Bitao Bu; Inez Vincent
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

5.  Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice.

Authors:  Sandra Sivilia; Luca Lorenzini; Alessandro Giuliani; Marco Gusciglio; Mercedes Fernandez; Vito Antonio Baldassarro; Chiara Mangano; Luca Ferraro; Vladimiro Pietrini; Maria Francesca Baroc; Arturo R Viscomi; Simone Ottonello; Gino Villetti; Bruno P Imbimbo; Laura Calzà; Luciana Giardino
Journal:  BMC Neurosci       Date:  2013-04-05       Impact factor: 3.288

6.  A screen for inducers of p21(waf1/cip1) identifies HIF prolyl hydroxylase inhibitors as neuroprotective agents with antitumor properties.

Authors:  Thong C Ma; Brett Langley; Brian Ko; Na Wei; Irina G Gazaryan; Neela Zareen; Darrell J Yamashiro; Dianna E Willis; Rajiv R Ratan
Journal:  Neurobiol Dis       Date:  2012-08-27       Impact factor: 5.996

Review 7.  Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?

Authors:  Glen E Kisby; Peter S Spencer
Journal:  Int J Environ Res Public Health       Date:  2011-09-29       Impact factor: 3.390

8.  Photoreceptor proliferation and dysregulation of cell cycle genes in early onset inherited retinal degenerations.

Authors:  Kristin L Gardiner; Louise Downs; Agnes I Berta-Antalics; Evelyn Santana; Gustavo D Aguirre; Sem Genini
Journal:  BMC Genomics       Date:  2016-03-11       Impact factor: 3.969

Review 9.  Mechanism-based treatments for Alzheimer's disease.

Authors:  Peter Davies; Jeremy Koppel
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

10.  Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds).

Authors:  Thomas M Wishart; Helen N Pemberton; Sally R James; Chris J McCabe; Thomas H Gillingwater
Journal:  Genome Biol       Date:  2008-06-20       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.